Literature DB >> 9440119

Lipopolysaccharide-induced cytokine cascade and lethality in LT alpha/TNF alpha-deficient mice.

F Amiot1, C Fitting, K J Tracey, J M Cavaillon, F Dautry.   

Abstract

BACKGROUND: Tumor necrosis factor alpha (TNF-alpha) is often considered the main proinflammatory cytokine induced by lipopolysaccharide (LPS) and consequently the critical mediator of the lethality associated with septic shock.
MATERIALS AND METHODS: We used mice carrying a deletion of both the lymphotoxin alpha (LT-alpha) and TNF-alpha genes to assess the role of TNF in the cytokine cascade and lethality induced by LPS.
RESULTS: Initial production of IL-1 alpha, IL-1 beta, IL-6, and IL-10 is comparable in wild-type and mutant mice. However, at later times, expression of IL-1 alpha, IL-1 beta, and IL-10 is prolonged, whereas that of IL-6 decreases in mutant mice. Expression of IFN-gamma is almost completely abrogated in mutants, which is in agreement with a more significant alteration of the late phase of the cytokine cascade. We measured similar LD50 (600 micrograms) for the intravenous injection of LPS in mice of the three genotypes (+/+, +/-, -/-), demonstrating that the absence of TNF does not confer long-term protection from lethality. However, death occurred much more slowly in mutant mice, who were protected more efficiently from death by CNI 1493, an inhibitor of proinflammatory cytokine production, than were wild-type mice. DISCUSSION: Thus, while TNF-alpha is not required for the induction of these cytokines by LPS, it modulates the kinetics of their expression. The lethality studies simultaneously confirm a role for TNF as a mediator of early lethality and establish that, in the absence of these cytokines, other mediators take over, resulting in the absence of long-term protection from LPS toxicity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440119      PMCID: PMC2230288     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  69 in total

1.  The production of TNF alpha and IL-8 in whole blood assays are differently regulated upon activation by LPS.

Authors:  J M Cavaillon; C Marie; C Pitton; C Fitting
Journal:  Prog Clin Biol Res       Date:  1995

2.  Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice.

Authors:  S L Erickson; F J de Sauvage; K Kikly; K Carver-Moore; S Pitts-Meek; N Gillett; K C Sheehan; R D Schreiber; D V Goeddel; M W Moore
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

3.  Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.

Authors:  M G Netea; W L Blok; B J Kullberg; M Bemelmans; M T Vogels; W A Buurman; J W van der Meer
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

4.  Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.

Authors:  J Barsig; S Küsters; K Vogt; H D Volk; G Tiegs; A Wendel
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

5.  Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin.

Authors:  L E Sower; C J Froelich; D H Carney; J W Fenton; G R Klimpel
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

6.  Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

Authors:  I Garcia; Y Miyazaki; K Araki; M Araki; R Lucas; G E Grau; G Milon; Y Belkaid; C Montixi; W Lesslauer
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

7.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Authors:  E Abraham; R Wunderink; H Silverman; T M Perl; S Nasraway; H Levy; R Bone; R P Wenzel; R Balk; R Allred
Journal:  JAMA       Date:  1995 Mar 22-29       Impact factor: 56.272

8.  Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors.

Authors:  W G Junger; D B Hoyt; H Redl; F C Liu; W H Loomis; J Davies; G Schlag
Journal:  Shock       Date:  1995-03       Impact factor: 3.454

9.  Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Authors:  P J Sansonetti; J Arondel; J M Cavaillon; M Huerre
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  PEG-BP-30 monotherapy attenuates the cytokine-mediated inflammatory cascade in baboon Escherichia coli septic shock.

Authors:  N J Espat; J C Cendan; E A Beierle; T A Auffenberg; J Rosenberg; D Russell; J S Kenney; E Fischer; W Montegut; S F Lowry
Journal:  J Surg Res       Date:  1995-07       Impact factor: 2.192

View more
  19 in total

Review 1.  Innate immunity and inflammation: a transcriptional paradigm.

Authors:  J Hawiger
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Should we inhibit type I interferons in sepsis?

Authors:  Tina Mahieu; Claude Libert
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

3.  Tissue destruction induced by Porphyromonas gingivalis infection in a mouse chamber model is associated with host tumor necrosis factor generation.

Authors:  Yuh-Yih Lin; Jan-Hung Huang; Yo-Yin Lai; Han-Ching Huang; Suh-Woan Hu
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia.

Authors:  N Honma; H Koseki; T Akasaka; T Nakayama; M Taniguchi; I Serizawa; H Akahori; M Osawa; T Mikayama
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

5.  Autophagy genes in myeloid cells counteract IFNγ-induced TNF-mediated cell death and fatal TNF-induced shock.

Authors:  Anthony Orvedahl; Michael R McAllaster; Amy Sansone; Bria F Dunlap; Chandni Desai; Ya-Ting Wang; Dale R Balce; Cliff J Luke; Sanghyun Lee; Robert C Orchard; Maxim N Artyomov; Scott A Handley; John G Doench; Gary A Silverman; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

6.  Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo.

Authors:  M Trahey; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  The triterpenoid CDDO-imidazolide reduces immune cell infiltration and cytokine secretion in the KrasG12D;Pdx1-Cre (KC) mouse model of pancreatic cancer.

Authors:  Ana S Leal; Michael B Sporn; Patricia A Pioli; Karen T Liby
Journal:  Carcinogenesis       Date:  2016-09-22       Impact factor: 4.944

Review 8.  The inflammasome: pathways linking psychological stress, depression, and systemic illnesses.

Authors:  Masaaki Iwata; Kristie T Ota; Ronald S Duman
Journal:  Brain Behav Immun       Date:  2012-12-20       Impact factor: 7.217

9.  Lipopolysaccharide-induced increases in cytokines in discrete mouse brain regions are detectable using Luminex xMAP technology.

Authors:  Subhash C Datta; Mark R Opp
Journal:  J Neurosci Methods       Date:  2008-08-14       Impact factor: 2.390

10.  FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells.

Authors:  Irina Lubarski-Gotliv; Carol Asher; Laura A Dada; Haim Garty
Journal:  J Biol Chem       Date:  2016-03-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.